吉西他滨
參見

1 2 3  . Drugs.com.   [6 May 2017]. （原始内容存档于2014-05-25）.
↑  赵可新,胡建平,单靖珊,等.盐酸吉西他滨临床应用进展[J].中国医药导报, 2006(36):3.DOI:10.3969/j.issn.1673-7210.2006.36.004.
↑  . Cancer Care Ontario.   [2020-12-06].
1 2 3 4 5 6 7 8 9 10  . The American Society of Health-System Pharmacists.   [2016-12-08]. （原始内容存档于2017-02-02）.
1 2 3  . National Cancer Institute. 2006-10-05  [2017-04-22]. （原始内容存档于2017-04-05）.
↑  李林均, 陳元. 吉西他濱對非小細胞肺癌細胞株A-549放療增敏的機制. 武漢大學學報(醫學版), 2008, 29(1): 98-101.
↑  Li Y, Li P, Li Y, Zhang R, Yu P, Ma Z,  et al. . Antiviral Research. December 2020, 184: 104967. PMID 33137361. doi:10.1016/j.antiviral.2020.104967 . hdl:1765/133780 .
↑  Fischer J, Ganellin CR. . John Wiley & Sons. 2006: 511. ISBN 9783527607495.
1 2  Myers C. . FierceBiotech. 2009-03-13. （原始内容存档于2017-09-11） （英语）.
1 2  . Hospira via News-Medical.Net. 2010-11-16. （原始内容存档于2015-10-02） （英语）.
↑  World Health Organization. . Geneva: World Health Organization. 2023. hdl:10665/371090 . WHO/MHP/HPS/EML/2023.02.
1 2 3 4 5 6 7  . UK Electronic Medicines Compendium. 2014-06-05  [2017-05-06]. （原始内容存档于2017-07-10） （英语）.
1 2   (PDF). FDA. June 2014  [2017-05-06]. （原始内容存档 (PDF)于2017-02-16）.  For label updates see FDA index page for NDA 020509 的存檔，存档日期2017-04-29.
↑  Zhang XW, Ma YX, Sun Y, Cao YB, Li Q, Xu CA. . Targeted Oncology. June 2017, 12 (3): 309–321. PMID 28353074. S2CID 3833614. doi:10.1007/s11523-017-0486-5.
↑  Plentz RR, Malek NP. . Visceral Medicine. December 2016, 32 (6): 427–430. PMC 5290432 . PMID 28229078. doi:10.1159/000453084.
↑  Jain A, Kwong LN, Javle M. . Current Treatment Options in Oncology. November 2016, 17 (11): 58. PMID 27658789. S2CID 25477593. doi:10.1007/s11864-016-0432-2.
1 2  . Macmillan Cancer Support.   [2017-05-06]. （原始内容存档于2017-03-25）.
↑  Rachel Airley. . Wiley-Blackwell. 2009. ISBN 978-0-470-09254-5.
↑  Siddall E, Khatri M, Radhakrishnan J. . Kidney International. July 2017, 92 (1): 37–46. PMID 28318633. doi:10.1016/j.kint.2016.11.029 .
↑  Kasi PM. . Case Reports in Oncology. January 2011, 4 (1): 143–148. PMC 3114619 . PMID 21691573. doi:10.1159/000326801.
1 2 3 4 5 6 7 8 9  Alvarellos ML, Lamba J, Sangkuhl K, Thorn CF, Wang L, Klein DJ,  et al. . Pharmacogenetics and Genomics. November 2014, 24 (11): 564–574. PMC 4189987 . PMID 25162786. doi:10.1097/fpc.0000000000000086.
1 2 3 4 5 6  Mini E, Nobili S, Caciagli B, Landini I, Mazzei T. . Annals of Oncology. May 2006, 17 (Suppl 5): v7–12. PMID 16807468. doi:10.1093/annonc/mdj941 .
↑  Fatima, M., Iqbal Ahmed, M. M., Batool, F., Riaz, A., Ali, M., Munch-Petersen, B., & Mutahir, Z. (2019). Recombinant deoxyribonucleoside kinase from Drosophila melanogaster can improve gemcitabine based combined gene/chemotherapy for targeting cancer cells. Bosnian Journal of Basic Medical Sciences, 19(4), 342-349. https://doi.org/10.17305/bjbms.2019.4136
↑  Cerqueira NM, Fernandes PA, Ramos MJ. . Chemistry: A European Journal. 2007, 13 (30): 8507–8515. PMID 17636467. doi:10.1002/chem.200700260.
↑  張雲嵩、田莉等.吉西他濱在多種腫瘤中的應用.重慶醫學，2018，第20期，第47卷：P2724-2728
↑  Brown K, Weymouth-Wilson A, Linclau B. . Carbohydrate Research. April 2015, 406: 71–75. PMID 25681996. doi:10.1016/j.carres.2015.01.001 .
↑  Brown K, Dixey M, Weymouth-Wilson A, Linclau B.  (PDF). Carbohydrate Research. March 2014, 387: 59–73. PMID 24636495. doi:10.1016/j.carres.2014.01.024.
↑  Sneader, Walter. . New York: Wiley. 2005: 259. ISBN 978-0-471-89979-2.
↑  . European Medicines Agency. 2008-09-24. （原始内容存档于2017-09-11） （英语）.
↑  Myers C. . FiercePharma. 2009-08-18. （原始内容存档于2017-09-11） （英语）.
↑  Holman CM.  (PDF). Missouri Law Review. Summer 2011, 76 (3): 645–693  [2017-05-06]. （原始内容 (PDF)存档于2017-09-11）.
1 2  Ravicher DB. . Seeking Alpha. 2010-07-28. （原始内容存档于2012-12-09）.
↑  Wang MH, Alexandre D. . Iimura T, Wang MH, Voit TJ, Rader RR  (编). . Cambridge Scholars Publishing. 2015: 119. ISBN 9781443879262. （原始内容存档于2017-09-11） （英语）.
↑  Dyawanapelly S, Kumar A, Chourasia MK. . Critical Reviews in Therapeutic Drug Carrier Systems. 2017, 34 (1): 63–96. PMID 28322141. doi:10.1615/CritRevTherDrugCarrierSyst.2017017912.
↑  Birhanu G, Javar HA, Seyedjafari E, Zandi-Karimi A. . Biomedicine & Pharmacotherapy. April 2017, 88: 635–643. PMID 28142120. doi:10.1016/j.biopha.2017.01.071.
↑  Dubey RD, Saneja A, Gupta PK, Gupta PN. . European Journal of Pharmaceutical Sciences. October 2016, 93: 147–162. PMID 27531553. doi:10.1016/j.ejps.2016.08.021.
↑  Pishvaian MJ, Brody JR. . Oncology. March 2017, 31 (3): 159–66, 168. PMID 28299752. （原始内容存档于2017-07-03）.
↑  Krown SE. . Current Opinion in Oncology. September 2011, 23 (5): 463–468. PMC 3465839 . PMID 21681092. doi:10.1097/cco.0b013e328349428d.
拉里·赫特爾等人在1988年於禮來實驗室所開發並發表之原始合成途徑。